E8A-42026-98715
5 vaccinations
5 coded responses
41 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 920 / CA
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Registered in v-safe
-
2021-01-16
Dose 1 — Moderna
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-30
- 2021-02-06
-
2021-02-13
Dose 2 — Moderna
- 2021-02-13
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-15
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Good · Site: Pain · Muscle or body achesFree text: Temp 99.3 evening of 2/14 (post injection day #1), after v-safe check inMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body achesAdult check-in
- 2021-02-20
- 2021-02-27
- 2021-03-07
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-05-15
-
2021-08-14
Survey response — 6 months, dose 2MedDRA: Throat irritation — Feeling: PoorFree text: Scratchy throatMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-02
Dose 3 — Moderna
-
2022-02-13
Survey response — 12 months, dose 2MedDRA: Hypertension, Vertigo — Feeling: Good · Be unable to do your normal daily activitiesFree text: Hypertension; episodic vertigoMedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Dose 4 — Moderna
- 2022-04-23
- 2022-04-24
- 2022-04-25
- 2022-05-02
-
2022-05-09
Survey response — day 21, dose 4MedDRA: Diarrhoea, Exposure to SARS-CoV-2, SARS-CoV-2 test negative — Feeling: GoodFree text: Diarrhea on 4/28/22. Close contact with person who tested positive for COVID on 5/3/22. I remain asymptomatic, had negative home antigen tests and PCR 5/8/22 negativeMedDRA releases: 2024-11 · check-in free text available
- 2022-05-16
- 2022-05-23
- 2022-05-30
- 2022-07-18
-
2022-09-25
Dose 5 — Pfizer-BioNTech
- 2022-10-05
- 2022-10-09
-
2022-10-16
Survey response — day 21, dose 5MedDRA: Arthralgia — Feeling: GoodFree text: Pain in hip and kneeMedDRA releases: 2024-11 · check-in free text available
- 2022-10-23
- 2022-10-30
- 2022-11-06
-
2022-12-25
Health check-in — 3 months, dose 5Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Flu-like symptoms: scratchy throat for 2 days, followed by 12 days of fatigue, malaise, intermittent low grade fever, and rhinorrhea. At home COVID-19 tests negative on days 1, 3, and 8.Adult check-in · check-in free text available
- 2023-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Moderna | |
| 2 | 2021-02-13 | Moderna | |
| 3 | 2021-11-02 | Moderna | No |
| 4 | 2022-04-18 | Moderna | No |
| 5 | 2022-09-25 | Pfizer-BioNTech | No |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Temp 99.3 evening of 2/14 (post injection day #1), after v-safe check in
Release 9 — 6 months, dose 2
Symptoms: Scratchy throat
Release 11 — 12 months, dose 2
Symptoms: Hypertension; episodic vertigo
Release 11 — day 21, dose 4
Symptoms: Diarrhea on 4/28/22. Close contact with person who tested positive for COVID on 5/3/22. I remain asymptomatic, had negative home antigen tests and PCR 5/8/22 negative
Release 12 — day 21, dose 5
Symptoms: Pain in hip and knee
Release 12 — 3 months, dose 5
Symptoms: Flu-like symptoms: scratchy throat for 2 days, followed by 12 days of fatigue, malaise, intermittent low grade fever, and rhinorrhea. At home COVID-19 tests negative on days 1, 3, and 8.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Throat irritation | ✓ | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release